HighTower Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,766
| Closed | -$1.03M | – | 3509 |
|
|
2021
Q1 | $1.03M | Sell |
4,766
-4,282
| -47% | -$805K | ﹤0.01% | 1541 |
|
|
2020
Q4 | $1.05M | Sell |
9,048
-51
| -0.6% | -$5.71K | ﹤0.01% | 1243 |
|
|
2020
Q3 | $888K | Buy |
9,099
+564
| +7% | +$64.9K | ﹤0.01% | 1270 |
|
|
2020
Q2 | $1.05M | Sell |
8,535
-1,329
| -13% | -$151K | 0.01% | 1101 |
|
|
2020
Q1 | $864K | Buy |
9,864
+97
| +1% | +$10.3K | 0.01% | 1081 |
|
|
2019
Q4 | $1.02M | Buy |
9,767
+2,544
| +35% | +$285K | 0.01% | 1141 |
|
|
2019
Q3 | $832K | Buy |
7,223
+511
| +8% | +$77.6K | ﹤0.01% | 1264 |
|
|
2019
Q2 | $1.15M | Buy |
6,712
+2,019
| +43% | +$349K | 0.01% | 1128 |
|
|
2019
Q1 | $792K | Buy |
4,693
+312
| +7% | +$46.4K | 0.01% | 1235 |
|
|
2018
Q4 | $425K | Sell |
4,381
-697
| -14% | -$91.4K | ﹤0.01% | 1436 |
|
|
2018
Q3 | $877K | Sell |
5,078
-1,069
| -17% | -$154K | 0.01% | 1189 |
|
|
2018
Q2 | $859K | Buy |
6,147
+2,481
| +68% | +$352K | 0.01% | 1192 |
|
|
2018
Q1 | $412K | Buy |
3,666
+504
| +16% | +$63.4K | ﹤0.01% | 1519 |
|
|
2017
Q4 | $418K | Buy |
3,162
+656
| +26% | +$77.1K | ﹤0.01% | 1534 |
|
|
2017
Q3 | $255K | Sell |
2,506
-359
| -13% | -$38.4K | ﹤0.01% | 1775 |
|
|
2017
Q2 | $290K | Buy |
2,865
+821
| +40% | +$88.4K | ﹤0.01% | 1644 |
|
|
2017
Q1 | $247K | Buy |
2,044
+191
| +10% | +$23.4K | ﹤0.01% | 1658 |
|
|
2016
Q4 | $208K | Buy |
+1,853
| New | +$223K | ﹤0.01% | 1659 |
|
|
2016
Q3 | – | Sell |
-2,199
| Closed | -$203K | – | 1977 |
|
|
2016
Q2 | $203K | Buy |
+2,199
| New | +$185K | ﹤0.01% | 1495 |
|
|
2016
Q1 | – | Sell |
-2,988
| Closed | -$202K | – | 2212 |
|
|
2015
Q4 | $202K | Buy |
2,988
+576
| +24% | +$46.9K | ﹤0.01% | 1741 |
|
|
2015
Q3 | $228K | Sell |
2,412
-1,464
| -38% | -$163K | ﹤0.01% | 1587 |
|
|
2015
Q2 | $476K | Buy |
3,876
+178
| +5% | +$20.2K | 0.01% | 1028 |
|
|
2015
Q1 | $337K | Buy |
+3,698
| New | +$300K | 0.01% | 1199 |
|
|
2014
Q4 | – | Sell |
-3,568
| Closed | -$288K | – | 1677 |
|
|
2014
Q3 | $288K | Buy |
+3,568
| New | +$316K | ﹤0.01% | 1224 |
|
Other funds holding GWPH
HighTower Advisors's GWPH Position: Q2 2021 in Review
HighTower Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 4,766 shares — an estimated $1.03M sold.
HighTower Advisors first reported a position in GWPH in Q3 2014 and held it in 24 quarters. The position peaked at $1.15M in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- HighTower Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- HighTower Advisors sold 4,766 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.03M.
- HighTower Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2014 and held it in 24 quarters.
- HighTower Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.15M in Q2 2019.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on HighTower Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.